Coherus Oncology
CHRS
CHRS
186 hedge funds and large institutions have $1.21B invested in Coherus Oncology in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 62 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less funds holding
Funds holding: 188 → 186 (-2)
7% less capital invested
Capital invested by funds: $1.31B → $1.21B (-$97.4M)
Holders
186
Holding in Top 10
3
Calls
$3.88M
Puts
$3.45M
Top Buyers
| 1 | +$32.8M | |
| 2 | +$30.5M | |
| 3 | +$17M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$10.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$9.88M |
Top Sellers
| 1 | -$34.6M | |
| 2 | -$11.8M | |
| 3 | -$11.3M | |
| 4 |
Holocene Advisors
New York
|
-$10.7M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$8.81M |